Accelerated Approval: Nippon Shinyaku’s Viltepso Fails DMD Confirmatory Trial, Raising Questions

 
• By Sue Sutter
Trail blazes
Viltepso followed the accelerated approval trail blazed by Exondys 51, but reported confirmatory trial results faster. • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews